跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pyresaph-125 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pyresaph-125
Approved
STANDARD
Pyresaph-125
Enicar Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fdad2ca9f576ceed
Company
Enicar Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
fdad2ca9f576ceed
Drug Approval Philippines Name
Pyresaph-125
Product Name
Pyresaph-125
Registration Number
DRP-9566
Brand Name
Pyresaph-125
Generic Name
Paracetamol
Dosage Form
Suspension
Dosage Strength
125mg/5mL
Manufacturer
Enicar Pharmaceuticals Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
26 February 2021
Expiry Date
26 February 2026
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fdad2ca9f576ceed
Type
Standard
Back to Philippines FDA Approvals